QA: Celularity Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001752828_2026_Celularity_Inc.pdf

Logs

Graph

Absolute values for 0001752828, Celularity Inc

  xvar xval
0 AssetsCurrent 12,319,000
1 IntangibleAssetsNetIncludingGoodwill 15,103,000
2 PropertyPlantAndEquipmentNet 55,797,000
3 remainder_Assets 24,110,000
4 LiabilitiesCurrent 80,759,000
5 LiabilitiesNoncurrent 29,963,000
6 remainder_Liabilities 34,669,000
7 CostOfGoodsAndServicesSold 22,673,054
8 SellingGeneralAndAdministrativeExpense 51,702,232
9 ResearchAndDevelopmentExpense 15,166,058
10 remainder_Expenses 1,486,697
11 remainder_Revenues 37,800,258
12 remainder_NetIncome -33,162,624
13 remainder_ComprehensiveNetIncome 1,530
  yvar yval
0 Assets 107,329,000
1 Liabilities 145,391,000
2 Expenses 91,028,041
3 Revenues 37,800,258
4 StockholdersEquity -38,062,000
5 NetIncome -86,390,407
6 ComprehensiveNetIncome -86,389,642
7 BaseVar 207,356,226
8 EconomicCapitalRatiobeforeLimitedLiability -1.34
9 EconomicCapitalRatio 1.22

Edgar->Model Mapping

Feature Distribution

Change over Time